Prestige Consumer Healthcare, Inc: 1QFY26 Results Light on Clear Eyes Supply Constraints

138 Views14 Aug 2025 05:50
Issuer-paid
PBH reported 1QFY26 adjusted EPS of $0.95 versus $0.90 in 1QFY25, up 5.6% Y/Y, but below our $1.04 estimate and FactSet consensus of $1.00.
What is covered in the Full Insight:
  • Introduction to PBH's 1QFY26 Results
  • Sales Performance and Challenges
  • Earnings Analysis and Forecast Adjustments
  • Supply Chain Updates and Strategic Actions
  • Conclusion and Analyst Outlook
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
chart-bar
Price Chart(Sign Up to Access)
analytics-chart
  • Loading...
x